XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 29,804 $ 39,017 $ 48,677
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Provision for (recovery of) credit losses 849 2,474 (1,066)
Amortization of discounts on acquired loan and deferred fees, net 488 681 (7,016)
Depreciation and amortization 2,816 3,174 3,452
Net amortization of premiums on investment securities 1,383 1,828 2,435
Net gain on sale of securities (5) (8) (28)
Mortgage banking $ (3,383) $ (5,073) $ (16,058)
Type of Revenue [Extensible List] us-gaap:MortgageBankingMember us-gaap:MortgageBankingMember us-gaap:MortgageBankingMember
Tri-Net $ (84) $ (78) $ (8,613)
SBA lending (3,323) (2,501) (2,060)
Net gain on disposal of premises and equipment (5) (14) (21)
Net gain on sale of other real estate owned 0 (102) (49)
Stock-based compensation 1,677 1,355 1,600
Deferred income tax expense (benefit) 88 470 (207)
Origination of loans held for sale (240,980) (685,622) (1,288,434)
Proceeds from loans held for sale 260,214 626,778 1,397,992
Cash payments arising from operating leases (2,352) (2,194) (2,074)
Amortization of debt issuance expense 134 134 109
Net (increase) decrease in accrued interest receivable and other assets 82 (2,829) (15,318)
Net increase (decrease) in accrued interest payable and other liabilities (3,045) (1,207) 3,043
Net cash provided by (used in) operating activities 44,358 (23,717) 116,364
Cash flows from investing activities:      
Purchases 0 (68,895) (92,465)
Sales 2,506 0 0
Maturities, prepayments and calls 37,671 64,177 104,733
Maturities, prepayments and calls 1,230 515 600
Net redemption (purchase) of restricted equity securities 3,298 (2,179) 1,109
Net decrease (increase) in loans 41,952 (242,573) (57,110)
Purchase of premises and equipment (809) (981) (503)
Proceeds from the sale of premises and equipment 1,310 429 21
Proceeds from sale of other real estate 0 368 2,328
Proceeds from (purchases of) bank owned life insurance 802 0 (39,000)
Net cash provided by (used in) investing activities 87,960 (249,139) (80,287)
Cash flows from financing activities:      
Net increase (decrease) in deposits (17,567) (4,462) 116,280
Proceeds from Federal Home Loan Bank advances 535,500 395,000 0
Payments on Federal Home Loan Bank advances (500,500) (380,000) (10,000)
Repurchase of common stock (16,447) (9,574) (462)
Exercise of common stock options, net of repurchase of restricted shares 85 (79) 858
Common stock dividends paid (9,083) (7,849) (5,067)
Net cash provided by (used in) financing activities (8,012) (6,964) 101,609
Net increase (decrease) in cash and cash equivalents 124,306 (279,820) 137,686
Cash and cash equivalents at beginning of period 135,305 415,125 277,439
Cash and cash equivalents at end of period 259,611 135,305 415,125
Supplemental disclosures of cash paid:      
Interest paid 66,912 15,427 8,075
Income taxes paid 8,691 8,860 16,045
Supplemental disclosures of noncash transactions:      
Cumulative effect adjustment due to adoption of CECL accounting standard under ASC 326, net of taxes (3,444) 0 0
Transfer of loans to other real estate 11 0 2,022
Loans charged off to the allowance for credit losses on loans 1,176 756 647
Lease liabilities arising from obtaining right-of-use assets 721 570 0
Unrealized losses on securities available for sale, net of tax 4,784 (48,782) (8,998)
Loans transferred from held-for-sale to held-for-investment, net of loans from held-for-investment transferred to held-for-sale $ 0 $ 105,503 $ 18,396